Chang-Hyun Gil,Dibyendu Chakraborty,Cristiano P. Vieira,Nutan Prasain,Sergio Li Calzi,Ping Hu,Kimihiko Banno,Mohamed Jamal,Chao Huang,Micheli S. Sielski,Yang Lin,Xinxin Huang,Mariana Dupont,Jason L. Floyd,Ram Prasad,Ana Leda F. Longhini,Trevor J. McGill,Hyung-Min Chung,Michael P. Murphy,Darrell N. Kotton,Michael E. Boulton,Mervin C. Yoder,Maria B. Grant

Abstract:Human induced pluripotent stem cells (hiPSC) differentiated into a specific mesoderm subset expressing vascular endothelial growth factor receptor 2, neural cell adhesion molecule 1, and apelin G protein-coupled receptor APJ (called KNA+), possessed all of the phenotypic and functional endothelial colony forming cell potential that resides in differentiating hiPSC. Thus, we postulated KNA+ mesoderm treatment would correct diabetic retinal capillary vasodegeneration. KNA+ cells derived from diabetic (D) and non-diabetic (N) patient-derived hiPSC displayed comparable phenotypic and functional properties. N-KNA+ or D-KNA+ intravitreal injections into type II diabetic ( db/db ) murine eyes led to retinal vascular engraftment, showed no toxicity, visual acuity was significantly improved, and diabetes-induced scotopic and photopic ERG defects were corrected. Proteomic arrays revealed that hiPSC-derived KNA+ cell administration restored several aberrant cell signaling pathways in the neural retina. These results support the efficacy of both hiPSC-derived D-KNA+ and N-KNA+ cells in correcting vasodegeneration in the diabetic murine retina.

Establishment of a Human Induced Pluripotent Stem Cell Line (Csuasoi008-A) from a Type 2 Diabetic Patient with Retinopathy.

Establishment of a Human Induced Pluripotent Stem Cell Line (Csuasoi010-A) by Reprogramming Peripheral Blood Mononuclear Cells of a Type 2 Diabetic Mellitus Patient.

Advances in Reprogramming of Peripheral Blood Cells to Induced Pluripotent Stem Cells

Establishment of Induced Pluripotent Stem Cell Line (Zzui009-A) from an Alzheimer's Disease Patient Carrying a PSEN1 Gene Mutation

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

Establishment of a Human Induced Pluripotent Stem Cell Line (Csuasoi005-A), from Peripheral Blood Mononuclear Cells of a Patient with X-linked Juvenile Retinoschisis Carrying a Novel Mutation in RS1 Gene.

Establishment of Induced Pluripotent Stem Cell Line CSUASOi004-A by Reprogramming Peripheral Blood Mononuclear Cells of a PRPF6-related Dominant Retinitis Pigmentosa Patient.

Using Inducible Lentiviral Vectors to Generate Induced Pluripotent Stem Cell Line ZOCi001-A from Peripheral Blood Cells of a Patient with CRB1-/- Retinitis Pigmentosa.

Establishment of Induced Pluripotent Stem Cell Line CSUASOi003- A from an Autosomal Recessive Retinitis Pigmentosa Patient Carrying Compound Heterozygous Mutations in CRB1 Gene

Establishment of an Induced Pluripotent Stem Cell (ipsc) Line (Inndsui005-A) from a Healthy Female Chinese Han

Establishment of an Induced Pluripotent Stem Cell Line (Sdchi011-A) from a Healthy Chinese Female Donor

Generation of Human-Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2

Human Pluripotent Stem Cells from Diabetic and Nondiabetics Improve Retinal Pathology in Diabetic Mice

Establishment of an Induced Pluripotent Stem Cell (ipsc) Line (Inndsui001-A) from a Healthy Female Chinese Han.

Establishment of the induced pluripotent stem cell line SJTUGHi002-A from a CNGA1-related recessive retinitis pigmentosa patient

Establishment of a non-integrate iPS cell line CSUASOi002-A, from urine-derived cells of a female patient with macular corneal dystrophy carrying compound heterozygous CHST6 mutations.

Establishment of Non-Integrate Induced Pluripotent Stem Cell Line CSUASOi006-A, from Urine-Derived Cells of a PRPF8-related Dominant Retinitis Pigmentosa Patient

Establishment of CSUASOi001-A, a Non-Integrated Induced Pluripotent Stem Cell Line from Urine-Derived Cells of a Chinese Patient Carrying RS1 Gene Mutation.

Generation of a Human Induced Pluripotent Stem Cell Line (Shupli001-A) from PBMCs of a Healthy Male Donor.

Human Induced Pluripotent Stem Cell Derived Mesoderm Subset Ameliorates Diabetic Retinopathy by Reestablishing Retinal Function and Restoring Protective Signaling Cascades in Type 2 Diabetes

An Induced Pluripotent Stem Cell Line (Csui004-A) from Skin Fibroblasts of a Healthy Individual